Literature DB >> 12354744

In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung.

Masamichi Ono1, Yoshiki Sawa, Kunio Matsumoto, Toshikazu Nakamura, Yasufumi Kaneda, Hikaru Matsuda.   

Abstract

BACKGROUND: Recent studies have demonstrated that gene transfer with hepatocyte growth factor (HGF) induces angiogenesis for coronary and peripheral artery diseases. We investigated the ability of gene transfer with human HGF to induce angiogenesis in the rat lung. METHODS AND
RESULTS: The left lung was selectively transfected with a cDNA encoding human HGF via the left pulmonary artery, using the HVJ-liposome method (H group); rats transfected with the same vector lacking the HGF gene served as controls (C group). HGF gene transfer significantly increased the capillary density in the left lung compared with the C group 7 days after transfection (15.0+/-1.3 versus 8.0+/-1.7 mm(2), P<0.01). The left to right average blood perfusion ratio detected by laser Doppler imaging increased significantly in the H group 14 days after transfection (1.12+/-0.09 versus 0.91+/-0.11, P<0.01). A right pulmonary artery clamp test, in which only the left lung received all the pulmonary blood flow from the right ventricle, revealed that the increase in right ventricular pressure was significantly attenuated in the H group compared with the C group 7 days after transfection (8.6+/-3.5 versus 15.3+/-2.8 mm Hg, P<0.01).
CONCLUSIONS: Trans-pulmonary arterial transfer of the human HGF gene into the left lung increased capillary density and blood perfusion, and decreased vascular resistance when blood flow increased. These results suggest therapeutic angiogenesis induced by HGF gene expression in the lung may be found suitable in treating subjects with decreased pulmonary vasculature or increased pulmonary vascular resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354744

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction.

Authors:  Sonya B Sonnenberg; Aboli A Rane; Cassie J Liu; Nikhil Rao; Gillie Agmon; Sophia Suarez; Raymond Wang; Adam Munoz; Vaibhav Bajaj; Shirley Zhang; Rebecca Braden; Pamela J Schup-Magoffin; Oi Ling Kwan; Anthony N DeMaria; Jennifer R Cochran; Karen L Christman
Journal:  Biomaterials       Date:  2015-01-13       Impact factor: 12.479

2.  A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation.

Authors:  Ognoon Mungunsukh; Young H Lee; Ana P Marquez; Fabiola Cecchi; Donald P Bottaro; Regina M Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-01       Impact factor: 5.464

3.  Effects of hepatocyte growth factor in myocarditis rats induced by immunization with porcine cardiac myosin.

Authors:  Jota Nakano; Akira Marui; Hiroyuki Muranaka; Hidetoshi Masumoto; Hisashi Noma; Yasuhiko Tabata; Akio Ido; Hirohito Tsubouchi; Tadashi Ikeda; Ryuzo Sakata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-12-09

4.  Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion.

Authors:  Anil Karihaloo; S Ananth Karumanchi; William L Cantley; Shivalingappa Venkatesha; Lloyd G Cantley; Sujata Kale
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 5.  Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.

Authors:  Roshni Iyer; Connie C W Hsia; Kytai T Nguyen
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung.

Authors:  Gregory Seedorf; Alexander J Metoxen; Robert Rock; Neil Markham; Sharon Ryan; Thiennu Vu; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-01       Impact factor: 5.464

7.  The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats.

Authors:  Yinghua Guo; Longxiang Su; Yinghui Li; Na Guo; Lixin Xie; Dong Zhang; Xiaojun Zhang; Hongxia Li; Guizhi Zhang; Yajuan Wang; Changting Liu
Journal:  Heart Vessels       Date:  2013-08-10       Impact factor: 2.037

Review 8.  Genetic Delivery and Gene Therapy in Pulmonary Hypertension.

Authors:  Nabham Rai; Mazen Shihan; Werner Seeger; Ralph T Schermuly; Tatyana Novoyatleva
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

9.  Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.

Authors:  Shravani Pasupneti; Wen Tian; Allen B Tu; Petra Dahms; Eric Granucci; Aneta Gandjeva; Menglan Xiang; Eugene C Butcher; Gregg L Semenza; Rubin M Tuder; Xinguo Jiang; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

10.  Lactate dehydrogenase a expression is necessary to sustain rapid angiogenesis of pulmonary microvascular endothelium.

Authors:  Glenda Parra-Bonilla; Diego F Alvarez; Mikhail Alexeyev; Audrey Vasauskas; Troy Stevens
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.